Le@P Technology, Inc. Appoints Dr. Howard Benjamin Vice President of Research and Development

  
    
  
  
    
      Le@P Technology, Inc. (OTCBB:LPTC), a company focused on acquiring and 
      commercializing synergistic technologies to develop advanced products, 
      today announced the hiring of Howard Benjamin, Ph.D., as Vice President 
      of Research and Development. Dr. Benjamin has worked in the 
      pharmaceutical industry with a focus on drug discovery and development 
      for more than fifteen years. He joins Le@P from DAIAMED, LLC, where he 
      created and led their biology and preclinical programs. Prior to 
      DAIAMED, he was founding scientist of Pharmaceutical Peptides and Vice 
      President for Discovery Research of Praecis Pharmaceuticals.
    
    
      “Le@P is delighted to welcome Howard who 
      brings to the Company a wealth of experience in discovery research and 
      corporate level supervision,” said Donald 
      Ciappenelli, Ph.D., CEO of Le@P Technology. “Howard’s 
      background and leadership experience clearly strengthens our team and 
      will allow us to move aggressively and advance programs important to the 
      Company.” Dr. Ciappenelli continued, “Howard’s 
      joining us at this critical stage is most welcome timing. With his 
      technical and scientific expertise, as well as his skills in internal 
      and external corporate management and partnerships, he clearly has an 
      ideal background to contribute to our future success.”
    
    
      Commenting on his new position, Dr. Benjamin said, “I 
      am very pleased to be on board such an exciting venture that offers so 
      many possibilities for product development. I look forward to bringing 
      my experience in the field and leadership capabilities to the 
      opportunity to help take Le@P through its next stages of growth and 
      development, by seeking to bring exciting new products to market and 
      forge corporate partnerships.”
    
    
      Statements about Le@P’s future expectations, 
      including without limitation, future revenues and earnings, plans and 
      objectives for future operations, future agreements, future economic 
      performance, operations and all other statements in this press release 
      other than historical facts are “forward-looking 
      statements” within the meaning of Section 27A 
      of the Securities Act of 1933, Section 21E of the Securities Exchange 
      Act of 1934, and as that term is defined in the Private Securities 
      Litigation Reform Act of 1995. Le@P intends that such forward-looking 
      statements be subject to the safe harbor created thereby. Since these 
      statements involve risks and uncertainties, including but not limited to 
      economic, competitive, governmental, regulatory, contractual and 
      technological factors affecting Le@P’s 
      operations, markets and profitability, Le@P’s 
      actual performance could differ materially and adversely from its 
      projected results.